SNTI Senti Biosciences Inc
Company Analysis
Latest News
🟢 Senti Biosciences is trading 6.4% up in pre-market after positive Moderna-Merck Phase 3 melanoma-vaccine results
Senti Biosciences is trading 6.4% up now at $0.49 after biotechnology shares rallied following positive Phase 3 melanoma-vaccine results from Moderna and...
🟢 Senti Biosciences is trading 8.81% up today after positive Moderna-Merck cancer-vaccine results
Senti Biosciences is trading 8.81% up at $0.47 after biotech stocks rallied broadly on positive Moderna-Merck Phase 3 personalized cancer-vaccine results. -...
🟢 Senti Biosciences is trading 7% up in pre-market ahead of August 20 Q2 2026 earnings discussion
Senti Biosciences is trading 6.95% up at $0.46, with no clearly reported company-specific overnight catalyst identified for August 19, 2026. - Investor...
Senti Biosciences Inc Q2 2026 Earnings Preview: What Analysts Expect on August 20, 2026
Senti Biosciences (SNTI) is projected to report a Q2 2026 loss of $0.33 per share on revenue of approximately $0.015 million, with the stock trading near $0.45...
🟢 Senti Biosciences is trading 7% up in pre-market ahead of proposed merger vote and Q2 earnings announcement
Senti Biosciences is trading 6.98% up at $0.46 in pre-market ahead of its virtual annual shareholder meeting today, August 18, 2026, which includes a proposed...
Senti Biosciences Burns Through Its Cash Cushion — Can a Sub-Dollar Biotech Survive Past Year-End?
Shares of Senti Biosciences slid 10.4% to $0.40 on August 14 after the gene-circuit cell therapy company posted second-quarter results that were worse than...
🔴 Senti Biosciences is trading 10.4% down today after second-quarter adjusted EPS missed estimates
Senti Biosciences is trading 10.4% down now at $0.40 after second-quarter adjusted EPS of -$0.42 missed the -$0.26 estimate. - The company reported a $12.75...
🔴 Senti Biosciences is trading 8.53% down today with elevated volume but no confirmed catalyst
Senti Biosciences is trading 8.53% down now at $0.41, with no confirmed company-specific catalyst identified. - Available coverage identifies no new August 17...
🔴 Senti Biosciences is trading 5% down in pre-market
Senti Biosciences is trading 5.39% down now at $0.42 after closing at $0.45 on August 14, with no confirmed August 17 company-specific catalyst identified. -...
🔴 Senti Biosciences is trading 7.02% down in after-hours trading
Senti Biosciences is trading 7.02% down at $0.42 in after-hours trading, with no confirmed company-specific announcement explaining the decline. - It closed...
🟢 Senti Biosciences is trading 12.08% up today with no confirmed catalyst identified
Senti Biosciences is trading at $0.43, up 12.08%, with no confirmed company-specific catalyst identified for August 14, 2026. - Latest company materials...
🟢 Senti Biosciences is trading 5.5% up today with no confirmed corporate catalyst
Senti Biosciences is trading 5.47% up at $0.41, with no confirmed company-specific catalyst identified for the August 14, 2026 move. - No new company-specific...
🟢 Senti Biosciences is trading 6.3% up today amid risk-on sentiment; no company-specific catalyst identified
Senti Biosciences is trading 6.29% up now at $0.40, with the move appearing aligned with broader risk-on sentiment after cooler-than-expected July PPI and...
🟢 Senti Biosciences is trading 6.49% up today amid broader market strength
Senti Biosciences is trading at $0.38, up +6.49%, alongside broader market strength. - The Nasdaq Composite is up 0.72%, with investors focused on the July...
🟢 Senti Biosciences is trading 5% up today
Senti Biosciences is trading 5.07% up now at $0.37, but no new company-specific catalyst dated August 11, 2026 was identified. - The latest clearly documented...
🟢 Senti Biosciences is trading 6% up in pre-market amid broader sentiment, with no direct catalyst identified
Senti Biosciences is trading 5.88% up now at $0.38, with broader sentiment supportive but no verified company-specific announcement identified for August 7,...
Senti Biosciences Inc Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026
Senti Biosciences is expected to report a consensus revenue of $1.42 million and an EPS of -$0.33 for Q2 2026, while the stock currently trades at $2.45...
🟢 Senti Biosciences is trading 5.8% up today amid biotech sector rebound and risk-on sentiment
Senti Biosciences is trading 5.8% up at $0.39 as part of a broader rebound in biotech and a shift toward risk-on sentiment. • The move extends an 8.7% gain...
🟢 Senti Biosciences is trading 5.1% up today amid a broader biotech sector rebound
Senti Biosciences is trading at $0.39 (up 5.1%) in pre-market action, extending its gains from the previous session as the biotech sector continues to...
🟢 Senti Biosciences is trading 10.5% up today amid a biotech rebound and risk-on sentiment
Senti Biosciences is trading 10.5% up today at $0.38 amid a modest rebound in beaten-down biotech names and a generally risk-on tape. • There are no new...